Necrotizing enterocolitis (NEC) is a devastating intestinal disease that primarily affects premature infants in the neonatal intensive care unit (NICU). It develops when the bowel wall becomes inflamed, then necrotic, and can perforate within hours. NEC affects roughly 1 in 1,000 live births in the United States, but the incidence rises to 5–12% of infants born under 1,500 g.
The four pillars of NEC pathophysiology
Modern neonatology describes NEC as a "perfect storm" of four overlapping factors. None of them alone is sufficient, but together they trigger the inflammatory cascade that destroys intestinal tissue.
1. Intestinal immaturity
A preterm infant's gut is structurally and immunologically unfinished. Tight junctions between epithelial cells are leaky, mucus production is reduced, and secretory IgA is almost absent before 34 weeks. This means bacteria and feeding antigens can translocate across the bowel wall and trigger inflammation more easily than in a term infant.
2. Abnormal microbial colonization (dysbiosis)
Babies born vaginally and breastfed develop a microbiome dominated by Bifidobacteriumand Lactobacillus. NICU babies — often delivered by C-section, exposed to broad spectrum antibiotics, and fed formula — develop dysbiotic flora dominated by Proteobacteria (E. coli, Klebsiella, Enterobacter). These organisms produce endotoxin and ferment formula sugars into hydrogen, contributing to pneumatosis intestinalis on X-ray.
3. Ischemia and reperfusion injury
Preterm infants frequently have episodes of low mesenteric blood flow: patent ductus arteriosus, hypotension, indomethacin therapy, or umbilical line placement. When blood flow returns, reactive oxygen species damage already-fragile enterocytes.
4. Enteral feeding — especially cow's-milk-based formula
NEC almost always occurs after feedings have started. The type of feed matters enormously. The seminal Lucas & Cole study (Lancet, 1990) reported NEC in 7.2% of formula-fed preterm infants vs. 1.2% of exclusively human-milk fed infants — roughly a 6–10x increase in risk.
Cow's-milk proteins, the high osmolarity of fortifiers, and the absence of human milk's protective factors (lactoferrin, lysozyme, oligosaccharides, IgA, and growth factors) all plausibly contribute. The brands most often named in litigation — Similac Special Care (Abbott) and Enfamil Premature (Mead Johnson) — are cow's-milk-based and were marketed for NICU use without warnings about NEC.
Who is most at risk?
- Gestational age < 32 weeks — risk doubles for every two weeks earlier
- Birth weight < 1,500 g (very low birth weight)
- Formula-fed or mixed-fed infants vs. exclusive human milk
- Rapid advancement of feeds (> 30 mL/kg/day)
- Recent prolonged antibiotic exposure (> 5 days empiric)
- Hemodynamically significant patent ductus arteriosus
- Severe anemia or recent packed red blood cell transfusion (TANEC)
What this means for parents
If your baby was born premature and fed Similac Special Care or Enfamil Premature in the NICU, the formula was not the only factor — but evidence shows it was an avoidable one. Donor human milk was available at most level-III NICUs and is now recommended by the American Academy of Pediatrics when mother's own milk is insufficient.
Next, learn how NEC is recognized clinically: NEC symptoms and diagnosis, or see what treatment involves in our NEC treatment and surgery guide. If your baby's case may involve formula liability, take the eligibility check.